Physician profile
Rhett Mckey Shirley
NPI 1003825944
$2,144.26
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $396 · 2020: $132 · 2021: $94.34 · 2022: $396 · 2023: $664 · 2024: $462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,126.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,125.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $349.97 | 2019-2024 | Dovato, Rukobia, Cabenuva |
| Gilead Sciences, INC. | $337.60 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $288.40 | 2019-2024 | Pifeltro, Delstrigo, Dificid |
| Insmed, INC. | $241.29 | 2019-2023 | Arikayce |
| Modernatx, INC. | $152.92 | 2023-2024 | Moderna Covid-19 Vaccine |
| Melinta Therapeutics, LLC | $131.66 | 2022-2024 | Vabomere, Kimyrsa, Rezzayo |
| Abbvie INC. | $126.95 | 2021-2024 | Mavyret |
| Astellas Pharma US INC | $122.63 | 2019-2023 | Cresemba |
| Paratek Pharmaceuticals, INC. | $109.58 | 2020-2023 | Nuzyra |
| Theratechnologies INC. | $91.93 | 2019-2023 | Trogarzo, Egrifta |
| Ferring Pharmaceuticals INC. | $69.67 | 2023-2024 | Rebyota |
| Tetraphase Pharmaceuticals, INC. | $38.21 | 2019 | |
| Janssen Scientific Affairs, LLC | $19.67 | 2020 | |
| Integra Lifesciences Corporation | $17.04 | 2021 | |
| Pharming Healthcare, INC. | $16.91 | 2024 | Ruconest |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.30 | 2019 | |
| Vbi Vaccine (Delaware) INC. | $13.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhett Shirley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.